IMPRESS leads the way for cancer precision medicine

¶ 1 Leave a comment on paragraph 1 0 IMPRESS Norway is a national clinical study starting in 2021 working towards implementing cancer precision medicine in Norway.

¶ 2 Leave a comment on paragraph 2 0 As one of the initiators behind IMPRESS-Norway, Oslo Cancer Cluster is thrilled to see this national clinical study in cancer precision medicine become a reality.

¶ 3 Leave a comment on paragraph 3 0 Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease, according to the National Cancer Institute. Read more at the Oslo Cancer Cluster Web Site.